We use cookies to personalize content, improve site performance, and analyze traffic. We also share information about your site usage with our advertising and analytics partners. They may combine it with other data you have provided or that they have collected from your use of their services.
Customize
INB Team
September 22, 2026
Most affiliates skip Venezuela. The country has a reputation for difficult logistics, unpredictable traffic, and low purchasing power. The CPM data says otherwise.
This campaign ran Prolan, a prostatitis supplement, on Facebook in Venezuela using fully compliant white-hat creatives. No cloaking. No workarounds. One ad account, one campaign, active for over a week at the time of writing with zero bans and zero ad rejections.
Campaign snapshot:
| Metric | Result |
| Offer | Prolan (prostatitis) |
| GEO | Venezuela, Tier 3 |
| Traffic source | |
| Approach | White, fully compliant |
| Starting daily budget | $15 |
| Current daily budget | $25 |
| CPM | ~$1.20 |
| CTR | 11% |
| CR (click to lead) | 1.75% |
| Approval rate | 12% (running, still climbing) |
| Redemption rate | 50% across 102 leads |
| EPC | $0.12 |
| ROI | 30% (still growing as approvals come in) |
| Account bans | 0 |
| Ad rejections | 0 |
CPM at $1.20 is low for a Facebook market. The competition is thin because most buyers have written off Tier 3 Latin American countries or defaulted to Brazil and Colombia where costs are higher and the market is more saturated.
Prolan as a prostatitis offer fits Venezuela’s demographic well. The audience is older men, the creative angle addresses a real and common health concern, and COD logistics work in the main urban areas.
The white-hat approach is not a compromise here. It is the economic argument. At 12% approval rate on a Tier 3 COD market, the numbers already produce 30% ROI. That approval rate is 2 percentage points above INB’s stated average for this time window (22–27 July). And the redemption rate of 50% across 102 leads is strong enough that a payout bump is now on the table, which would push ROI above 50% without changing anything else in the campaign.
Two creatives are active in the campaign. They are structurally identical. The only difference is the background color.
That is not laziness. It is a test with one variable. CTR on both holds at 11%, which is high for a health offer on Facebook. There are no signs of fatigue. The campaign has been running for over a week with stable performance.
The creative approach is benefit-led, not fear-led. The copy addresses the symptom plainly, positions Prolan as a natural preventative rather than a cure, and stays within Facebook’s health advertising policies. The same principle that worked in Pakistan, where white creatives produced 18% approval versus 5% for aggressive approaches, applies here: the audience that reads a compliant ad and still fills out the form is the audience that answers the phone.
🌿 Read also: Nutra offer types explained.
One Facebook ad account. One Business Manager. One campaign. No agency account complexity.
The affiliate uses:
Total infrastructure cost per day is low enough that the campaign turns profit on any day with reasonable volume. The discrepancy between Keitaro and the network is minor, with the network showing slightly more leads, which is the normal direction of drift.
The budget moved from $15 to $20 to $25 with two to three days between each increase. CPL rose by about 5% through the scaling. CPM rose about 15% over the full period and has stabilized.
Neither number is a problem at this scale. Facebook’s algorithm needs time to recalibrate after a budget change. The gap between increases allowed the campaign to re-stabilize before the next push. Volume stayed consistent. A parallel duplicate campaign is also running without issues, which confirms the traffic source can absorb more budget.
The next step is a payout bump conversation with the network. At 50% redemption rate across 102 leads, the affiliate has a real case for a higher rate. If that bump comes through, the ROI picture changes substantially.
🌿 Read also: How to scale an offer after a successful test.
30% ROI sounds modest. The context makes it more interesting.
The campaign is still in progress. Approvals are still arriving from the call center. The affiliate estimates the final figure will be higher than 30%. The 12% approval rate is already 2 points above the July average for this period. With 50% of approved leads redeeming, the downstream quality is there.
The economic argument for white-hat approaches on COD nutra in Tier 3 markets is the same one the Pakistan case made. Cheap leads from aggressive creative lower the CPL. They also lower the approval rate, often sharply. At $12 to $13 per confirmed lead, the math on approval rate swings is unforgiving.
At Venezuela’s payout level and at 12% approval, even a 4-point drop in approval rate from black creative approaches would eliminate most of the margin. At 16% approval from white creative, the same traffic budget produces a different P&L entirely.
Venezuela works. The numbers prove it: 30% ROI, 11% CTR, 50% redemption rate, one account, zero bans, over a week of clean traffic on $15 a day scaling to $25.
The market is thin on competition precisely because most buyers skip it. CPM at $1.20 is low. The white-hat approach protects approval rate. The COD infrastructure handles the rest.
If you have been sitting on Venezuela, this is the signal. INB.bio runs Prolan in Venezuela with COD fulfillment, native call center support, and a personal manager from day one. Sign up for free and launch your first campaign this week.
